Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

• TAKENAKA Katsuto

  Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences

• NAGAFUJI Koji

  Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine

• TAKASE Ken

  Department of Hematology, Hamanomachi General Hospital

• KAMIMURA Tomohiko

  Department of Hematology, Harasanshin Hospital

• MORI Yasuo

  Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences

• ITO Yoshikiyo

  Department of Hematology, Harasanshin Hospital

• NISHI Yukiko

  Department of Hematology, Hamanomachi General Hospital

• HENZAN Hideho

  Department of Hematology, Hamanomachi General Hospital

• KATO Koji

  Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences

• HARADA Naoki

  Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences

• ETO Tetsuya

  Department of Hematology, Hamanomachi General Hospital

• MIYAMOTO Toshihiro

  Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences

• TESHIMA Takanori

  Center for Cellular and Molecular Medicine, Kyushu University Hospital

• AKASHI Koichi

  Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences

Journal

• Int J Hematol.

  Int J Hematol. 96 (1), 94-100, 2012-07-01

Keywords

• Allogeneic hematopoietic stem cell transplantation
• Cytomegalovirus infection
• Preemptive therapy
• Low-dose
• Valganciclovir

Details

• CRID: 1573950400520725376
• NII Article ID: 10030954633
• NII Book ID: AA10797094
• ISSN: 09255710
• Text Lang: en
• Data Source:
  • CiNii Articles